Orthofix Medical Inc. (OFIX) Current Ratio
- Current ratio · latest quarter: Value 2.84×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 2.84× | Current assets / current liabilities. $446.13M ÷ $157.01M ≈ 2.84× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 446.13M USD | Assets, Current |
| Current obligations | 157.01M USD | Liabilities, Current |
| Cash and equivalents | 103.81M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 135.82M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | 184.47M USD | Inventory, Net |
| Payables | 63.53M USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) | Long-term Debt, Current Maturities |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $446.13M | $157.01M | $103.81M | (m) | $135.82M | $184.47M | $63.53M | (m) | 2.84× |
| 2026-03-31 | $461.52M | $161.03M | $120.28M | (m) | $137.78M | $177.82M | $54.69M | (m) | 2.87× |
| 2025-12-31 | $416.85M | $170.48M | $82.03M | (m) | $135.75M | $172.32M | $58.39M | (m) | 2.45× |
| 2025-09-30 | $394.17M | $159.85M | $62.86M | (m) | $130.81M | $174.04M | $50.46M | (m) | 2.47× |
| 2025-06-30 | $395.83M | $148.38M | $65.61M | (m) | $129.56M | $172.99M | $45.10M | (m) | 2.67× |
| 2025-03-31 | $390.31M | $144.12M | $57.95M | (m) | $131.87M | $174.48M | $45.18M | (m) | 2.71× |
| 2024-12-31 | $433.29M | $168.63M | $83.24M | (m) | $134.71M | $189.45M | $48.80M | $0.00 | 2.57× |
| 2024-09-30 | $386.21M | $161.90M | $30.05M | (m) | $124.84M | $205.81M | $47.06M | $6.25M | 2.39× |
| 2024-06-30 | $386.06M | $155.97M | $26.37M | (m) | $125.36M | $210.04M | $50.36M | $4.69M | 2.48× |
| 2024-03-31 | $398.98M | $150.62M | $26.96M | (m) | $125.62M | $219.08M | $57.15M | $3.13M | 2.65× |
| 2023-12-31 | $420.44M | $165.22M | $33.11M | (m) | $128.10M | $222.17M | $58.36M | $1.25M | 2.54× |
| 2023-09-30 | $393.70M | $152.53M | $33.66M | (m) | $114.12M | $221.75M | $53.26M | (m) | 2.58× |
| 2023-06-30 | $399.35M | $141.80M | $37.61M | (m) | $112.32M | $222.47M | $51.35M | (m) | 2.82× |
| 2023-03-31 | $410.04M | $137.57M | $49.97M | (m) | $113.31M | $221.93M | $45.88M | (m) | 2.98× |
| 2022-12-31 | $255.99M | $83.62M | $50.70M | (m) | $82.86M | $100.15M | $27.60M | (m) | 3.06× |
| 2022-09-30 | $246.90M | $77.65M | $51.66M | (m) | $75.63M | $100.28M | $28.00M | (m) | 3.18× |
| 2022-06-30 | $255.19M | $81.10M | $59.54M | (m) | $77.07M | $97.17M | $32.32M | (m) | 3.15× |
| 2022-03-31 | $255.10M | $88.21M | $71.92M | (m) | $72.47M | $88.83M | $27.45M | (m) | 2.89× |
| 2021-12-31 | $269.52M | $105.83M | $87.85M | (m) | $78.56M | $82.97M | $26.46M | (m) | 2.55× |
| 2021-09-30 | $260.21M | $80.00M | $82.71M | (m) | $68.97M | $84.68M | $19.44M | (m) | 3.25× |
| 2021-06-30 | $258.45M | $81.65M | $79.97M | (m) | $73.45M | $81.55M | $20.09M | (m) | 3.17× |
| 2021-03-31 | $263.35M | $99.06M | $94.57M | (m) | $69.68M | $84.18M | $21.06M | (m) | 2.66× |
| 2020-12-31 | $270.38M | $103.90M | $96.29M | (m) | $72.42M | $84.64M | $23.12M | (m) | 2.60× |
| 2020-09-30 | $254.67M | $93.38M | $79.81M | (m) | $73.05M | $82.86M | $16.94M | (m) | 2.73× |
| 2020-06-30 | $343.57M | $89.60M | $172.89M | (m) | $67.41M | $82.05M | $14.91M | (m) | 3.83× |
| 2020-03-31 | $240.00M | $65.96M | $57.74M | (m) | $77.80M | $82.74M | $19.64M | (m) | 3.64× |
| 2019-12-31 | $260.55M | $84.88M | $69.72M | (m) | $86.81M | $82.40M | $19.89M | (m) | 3.07× |
| 2019-09-30 | $237.80M | $88.51M | $56.85M | (m) | $79.69M | $80.99M | $17.89M | (m) | 2.69× |
| 2019-06-30 | $232.83M | $67.98M | $52.14M | (m) | $80.59M | $79.14M | $19.52M | (m) | 3.42× |
| 2019-03-31 | $224.34M | $63.65M | $46.67M | (m) | $79.61M | $79.13M | $19.64M | (m) | 3.52× |
| 2018-12-31 | $244.64M | $85.91M | $69.62M | (m) | $77.75M | $76.85M | $17.99M | (m) | 2.85× |
| 2018-09-30 | $245.01M | $76.81M | $53.78M | (m) | $74.36M | $79.89M | $15.43M | (m) | 3.19× |
| 2018-06-30 | $237.43M | $63.94M | $45.69M | (m) | $74.40M | $81.73M | $14.45M | (m) | 3.71× |
| 2018-03-31 | $263.14M | $65.18M | $77.06M | (m) | $77.18M | $77.69M | $14.01M | (m) | 4.04× |
| 2017-12-31 | $251.80M | $79.41M | $81.16M | (m) | $63.44M | $81.33M | (m) | (m) | 3.17× |
| 2017-09-30 | $213.41M | $74.07M | $53.92M | (m) | $61.19M | $80.12M | $13.35M | (m) | 2.88× |
| 2017-06-30 | $198.60M | $65.10M | $44.33M | (m) | $61.21M | $75.87M | $14.24M | (m) | 3.05× |
| 2017-03-31 | $186.84M | $62.87M | $41.65M | (m) | $59.44M | $66.27M | $16.55M | (m) | 2.97× |
| 2016-12-31 | $194.37M | $83.44M | $39.57M | (m) | $57.85M | $63.35M | (m) | (m) | 2.33× |
| 2016-09-30 | $185.25M | $83.28M | $46.82M | (m) | $52.89M | $65.01M | (m) | (m) | 2.22× |
| 2016-06-30 | $177.99M | $77.20M | $40.48M | (m) | $56.44M | $61.33M | (m) | (m) | 2.31× |
| 2016-03-31 | $173.97M | $59.00M | $39.85M | (m) | $55.27M | $59.79M | (m) | (m) | 2.95× |
| 2015-12-31 | $212.25M | $81.99M | $63.66M | (m) | $59.84M | $57.56M | (m) | (m) | 2.59× |
| 2015-09-30 | $245.49M | $78.58M | $63.69M | (m) | $56.17M | $57.77M | (m) | (m) | 3.12× |
| 2015-06-30 | $235.21M | $64.91M | $55.95M | (m) | $58.36M | $59.22M | (m) | (m) | 3.62× |
| 2015-03-31 | $235.03M | $69.41M | $29.78M | (m) | $58.53M | $56.71M | (m) | (m) | 3.39× |
| 2014-12-31 | $219.00M | $66.44M | $36.81M | (m) | $61.36M | $59.85M | (m) | (m) | 3.30× |
| 2014-09-30 | $270.35M | $81.38M | $29.82M | (m) | $62.51M | $64.27M | (m) | (m) | 3.32× |
| 2014-06-30 | $292.68M | $83.09M | $28.92M | (m) | $63.32M | $70.90M | (m) | (m) | 3.52× |
| 2014-03-31 | $259.57M | $57.72M | $25.12M | (m) | $73.45M | $70.68M | (m) | (m) | 4.50× |
| 2013-12-31 | $265.11M | $70.35M | $28.92M | (m) | $70.81M | $72.68M | (m) | (m) | 3.77× |
| 2013-09-30 | $281.77M | $66.02M | $22.22M | (m) | $75.25M | $100.20M | (m) | (m) | 4.27× |
| 2013-06-30 | $296.40M | $71.57M | $27.37M | (m) | $90.83M | $94.94M | (m) | (m) | 4.14× |
| 2013-03-31 | $312.62M | $59.72M | $33.67M | (m) | $96.51M | $84.69M | (m) | (m) | 5.24× |
| 2012-12-31 | $300.63M | $65.33M | $30.77M | (m) | $103.80M | $69.81M | (m) | (m) | 4.60× |
| 2012-09-30 | $404.87M | $152.46M | $53.57M | (m) | $155.98M | $80.82M | (m) | (m) | 2.66× |
| 2012-06-30 | $396.39M | $146.05M | $50.09M | (m) | $149.47M | $78.42M | (m) | (m) | 2.71× |
| 2012-03-31 | $414.77M | $171.50M | $47.05M | (m) | $156.50M | $90.94M | (m) | $20.00M | 2.42× |
| 2011-12-31 | $531.13M | $183.70M | $33.21M | (m) | $99.89M | $81.53M | (m) | $17.50M | 2.89× |
| 2011-09-30 | $359.73M | $137.31M | $29.02M | (m) | $142.20M | $94.71M | (m) | $15.00M | 2.62× |
| 2011-06-30 | $346.10M | $133.21M | $27.48M | (m) | $139.24M | $97.98M | (m) | $12.50M | 2.60× |
| 2010-12-31 | $311.76M | $83.53M | $13.56M | (m) | $134.18M | $84.59M | (m) | $7.50M | 3.73× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |